SCLXW.US stock price determinants are multifaceted.

Market Sentiment: Overall investor confidence and the prevailing mood in the market significantly influence stock prices.

Company Performance: Sorrento Therapeutics' financial health, revenue growth, and profitability reports directly impact the perceived value of its warrants.

Industry Trends: Developments in the biotechnology and pharmaceutical sectors, particularly regarding pain management and oncology, can affect investor sentiment towards Sorrento.

Regulatory Approvals: FDA decisions on Sorrento's drug candidates or therapies have a substantial impact, with approvals typically driving prices up and rejections causing declines.

Clinical Trial Results: Data from clinical trials of Sorrento's products are crucial; positive results can increase investor confidence, while negative results can trigger sell-offs.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth influence investment decisions and can indirectly affect stock prices.

News and Events: Significant news related to Sorrento, such as partnerships, acquisitions, or legal proceedings, can cause rapid price fluctuations.

Analyst Ratings: Recommendations from financial analysts can sway investor opinion and affect trading activity, leading to price changes.

Trading Volume: High trading volume often indicates strong investor interest, which can amplify price movements.

Warrant Expiry Date: As the expiry date of the warrants approaches, the potential value diminishes if the underlying stock price is not significantly above the exercise price.

Underlying Stock Performance: The performance of Sorrento Therapeutics' common stock (SRNE.US) is a primary driver, as warrants derive their value from the potential to purchase common stock at a specified price.

Dilution: Potential dilution from new share issuances can negatively impact warrant value.

Risk Appetite: Investors' willingness to take risks influences demand for speculative assets like warrants.